Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
J&J's Alex Gorsky bagged $26M in pay and perks for 2021, landing near the top of the Big Pharma CEO ladder
4 years ago
People
Pharma
SEC issues preliminary injunction against Colorado biotech accused of $10M fraud
4 years ago
Pharma
Manufacturing
Beverly Hills plastic surgeon leads pharma manufacturing build in his native Ghana
4 years ago
Pharma
Manufacturing
Publicis brings back its HealthFront dealmaking marketplace for pharma and healthcare advertisers
4 years ago
Pharma
Marketing
Pharma industry reputation continues to slide, according to new Harris Poll. But how low can it go?
4 years ago
Pharma
Marketing
Negotiations or price controls? Senate Finance Committee splits along party lines over drug prices
4 years ago
Pharma
Roche uncorks new long-term data as SMA rivalry heats up
4 years ago
Pharma
Marketing
A watered-down Covid-19 vaccine IP waiver nears the finish line: Will it actually expand supplies?
4 years ago
Coronavirus
Law
Biogen closes out its ophthalmology R&D work, dumping off a C3 therapy
4 years ago
R&D
Biotech upstart rides the upsurge in radiopharma R&D to $88M round with marquee investors
4 years ago
Financing
Trying to nip at AstraZeneca's heels, Lilly and Boehringer Ingelheim stop a PhIII Jardiance study early in kidney ...
4 years ago
R&D
Sanofi partners up with dominant ADC player Seagen, doubling down on oncology in hunt for a better pipeline
4 years ago
Deals
R&D
Dermatology biotech Krystal settles lawsuit from former partner as it prepares first FDA pitch
4 years ago
Cell/Gene Tx
Law
With its share price chewed to pieces, Nick Leschly's 2seventy scores $170M to help weather the storm
4 years ago
Financing
Bioregnum
Biogen finally publishes PhIII results for Aduhelm as critics chastise low-ranking journal, ‘gentle and ...
4 years ago
Pharma
With new RSV antibody, Sanofi looks to avoid a repeat of a 20-year-old pricing controversy
4 years ago
R&D
Pharma
Back to the fundamentals: Frazier rolls out $1B fund to ramp up a new slate of biotech startups
4 years ago
Financing
Biotech founders sentenced to 1 year and 1 day for stealing Genentech secrets, lying to investors
4 years ago
People
Law
An Altos Labs rival? Genentech throws its hat into buzzy 'cellular rejuvenation' field
4 years ago
R&D
Pfizer pitches 4th Covid-19 vaccine shot for elderly despite mixed data from Israel
4 years ago
FDA+
Coronavirus
Government watchdog questions Eli Lilly's campaign contributions
4 years ago
Pharma
Novartis, Eli Lilly and AbbVie join growing list of Big Pharmas severing ties with Russia
4 years ago
Pharma
White House sounds the alarm on Covid-19 vaccine, monoclonal supply shortages
4 years ago
FDA+
Coronavirus
Cytiva opens doors at Cardiff site as part of $1.5B global expansion
4 years ago
Pharma
Manufacturing
First page
Previous page
557
558
559
560
561
562
563
Next page
Last page